CRON
Price
$2.37
Change
-$0.15 (-5.95%)
Updated
Aug 15 closing price
Capitalization
916.01M
80 days until earnings call
UPC
Price
$3.52
Change
-$0.04 (-1.12%)
Updated
Aug 15 closing price
Capitalization
1.98M
Interact to see
Advertisement

CRON vs UPC

Header iconCRON vs UPC Comparison
Open Charts CRON vs UPCBanner chart's image
Cronos Group
Price$2.37
Change-$0.15 (-5.95%)
Volume$2.68M
Capitalization916.01M
Universe Pharmaceuticals
Price$3.52
Change-$0.04 (-1.12%)
Volume$16.88K
Capitalization1.98M
CRON vs UPC Comparison Chart in %
Loading...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRON vs. UPC commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Hold and UPC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (CRON: $2.37 vs. UPC: $3.52)
Brand notoriety: CRON and UPC are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRON: 139% vs. UPC: 31%
Market capitalization -- CRON: $916.01M vs. UPC: $1.98M
CRON [@Pharmaceuticals: Generic] is valued at $916.01M. UPC’s [@Pharmaceuticals: Generic] market capitalization is $1.98M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 1 FA rating(s) are green whileUPC’s FA Score has 1 green FA rating(s).

  • CRON’s FA Score: 1 green, 4 red.
  • UPC’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRON and UPC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 6 TA indicator(s) are bullish while UPC’s TA Score has 6 bullish TA indicator(s).

  • CRON’s TA Score: 6 bullish, 4 bearish.
  • UPC’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, UPC is a better buy in the short-term than CRON.

Price Growth

CRON (@Pharmaceuticals: Generic) experienced а +3.04% price change this week, while UPC (@Pharmaceuticals: Generic) price change was -2.04% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Reported Earning Dates

CRON is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($916M) has a higher market cap than UPC($1.98M). CRON YTD gains are higher at: 17.327 vs. UPC (-85.574). UPC has higher annual earnings (EBITDA): -15.83M vs. CRON (-38.73M). CRON has more cash in the bank: 838M vs. UPC (8.86M). CRON has less debt than UPC: CRON (1.82M) vs UPC (6.51M). CRON has higher revenues than UPC: CRON (125M) vs UPC (26.7M).
CRONUPCCRON / UPC
Capitalization916M1.98M46,193%
EBITDA-38.73M-15.83M245%
Gain YTD17.327-85.574-20%
P/E Ratio47.40N/A-
Revenue125M26.7M468%
Total Cash838M8.86M9,456%
Total Debt1.82M6.51M28%
FUNDAMENTALS RATINGS
CRON: Fundamental Ratings
CRON
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
83
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRONUPC
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
Bullish Trend 20 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PQIPX13.90N/A
N/A
PIMCO Dividend and Income I2
FCASX30.18-0.02
-0.07%
Fidelity Advisor Asset Manager 70% C
SRIGX14.01-0.04
-0.28%
Gabelli SRI AAA
DQIRX34.05-0.14
-0.41%
BNY Mellon Equity Income Fund I
REBYX25.47-0.17
-0.66%
Russell Inv US Small Cap Equity Y

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-5.95%
SNDL - CRON
73%
Closely correlated
-4.27%
TLRY - CRON
60%
Loosely correlated
-12.71%
OGI - CRON
59%
Loosely correlated
-8.33%
CGC - CRON
59%
Loosely correlated
-12.75%
ACB - CRON
56%
Loosely correlated
-5.75%
More